Home » Topics » BioWorld Science

BioWorld Science
RSS

Synovir clinical program expanded

July 5, 1996

Phase III trials of Alferon N Injection initiated in HIV-positive patients

July 5, 1996

CPMP approves saquinavir for marketing

July 5, 1996

HIV protease inhibitors reported by Pharmacia & Upjohn

July 5, 1996

Glaxo Wellcome, Vertex license anti-HIV patents from Searle

July 5, 1996

MedImmune in-licenses HPV vaccine patents

July 5, 1996

Post-herpetic neuralgia data reviewed

July 5, 1996

MedImmune seeks Canadian approval for RespiGam

July 5, 1996

BMS describes antifungal effects of ascosteroside

July 5, 1996

Amphocil safe, effective in BMT patients

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...